Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial.
Friis RB, Pappot H, Hjollund NH, McCulloch T, Holt MI, Persson GF, Wedervang K, Clausen MM, Wahlstrøm S, Hansen KH, Rasmussen TR, Dalton SO, Jakobsen E, Linnet H, Skuladottir H; Danish Lung Cancer Group. Friis RB, et al. Among authors: wedervang k. JCO Oncol Pract. 2024 Dec 10:OP2400562. doi: 10.1200/OP-24-00562. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39657078
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).
Turner N, Saura C, Aftimos P, van den Tweel E, Oesterholt M, Koper N, Colleoni M, Kaczmarek E, Punie K, Song X, Armstrong A, Bianchi G, Stradella A, Ladoire S, Lim JSJ, Quenel-Tueux N, Tan TJ, Escrivá-de-Romaní S, O'Shaughnessy J; TULIP Trial Investigators. Turner N, et al. J Clin Oncol. 2024 Oct 23:JCO2400529. doi: 10.1200/JCO.24.00529. Online ahead of print. J Clin Oncol. 2024. PMID: 39442070
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Mau-Sørensen M, Gerner-Rasmussen J, Hansen O, Holm B, Nyhus CH, McCulloch T, Nielsen HA, Wedervang K, Rytter C, Jeppesen N, Langer SW. Mau-Sørensen M, et al. Among authors: wedervang k. Acta Oncol. 2023 Dec;62(12):1979-1982. doi: 10.1080/0284186X.2023.2278173. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37934081 Clinical Trial. No abstract available.
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mouritzen MT, Junker KF, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Homann PH, Kristensen EB, Drivsholm LB, Bøgsted M, Christensen HS, Pøhl M, Bjørnhart B. Mouritzen MT, et al. Among authors: wedervang k. Acta Oncol. 2022 Apr;61(4):409-416. doi: 10.1080/0284186X.2021.2023213. Epub 2022 Jan 11. Acta Oncol. 2022. PMID: 35012430 Free article.
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mouritzen MT, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Frary JMC, Drivsholm LB, Vesteghem C, Christensen HS, Bjørnhart B, Pøhl M. Mouritzen MT, et al. Among authors: wedervang k. Cancers (Basel). 2021 Sep 28;13(19):4846. doi: 10.3390/cancers13194846. Cancers (Basel). 2021. PMID: 34638329 Free PMC article.
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.
Ehmsen S, Jakobsen LH, Lendorf ME, Eefsen RL, Bentsen L, Knoop AS, Aggerholm-Pedersen N, Skuladottir H, Herrstedt J, Jensen LH, Rotbøl C, Damm MB, Wedervang K, Glenthøj A, Ryg J, Frederiksen H, Kodahl AR. Ehmsen S, et al. Among authors: wedervang k. Acta Oncol. 2021 Jul;60(7):859-865. doi: 10.1080/0284186X.2021.1889659. Epub 2021 Mar 1. Acta Oncol. 2021. PMID: 33646071
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.
Langkjer ST, Kenholm J, Jensen JD, Wedervang K, Brixen AT, Grunnet M, Stenbygaard L, Gilje B, Danø H, Glavicic V, Jacobsen EH, Brems-Eskildsen AS, Kruse HL, Dongsgaard T, Neimann J, Geisler J. Langkjer ST, et al. Among authors: wedervang k. Future Oncol. 2019 Aug;15(22):2561-2569. doi: 10.2217/fon-2019-0124. Epub 2019 Jun 19. Future Oncol. 2019. PMID: 31215242 Free article. Clinical Trial.
Sino-nasal cancer in Denmark 1982-1991--a nationwide survey.
Grau C, Jakobsen MH, Harbo G, Svane-Knudsen V, Wedervang K, Larsen SK, Rytter C. Grau C, et al. Among authors: wedervang k. Acta Oncol. 2001;40(1):19-23. doi: 10.1080/028418601750070993. Acta Oncol. 2001. PMID: 11321654
11 results